Cell therapy is the delivery of living cells to treat, or potentially cure, a person’s disease. The transplantation of hematopoietic stem cells from a donor to a recipient to create bone marrow ...

British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence ...

Average actual manufacturing time of cell therapy is 15 days, according to Maria Whitman, global lead of pharma and biotech practice at the consultancy ZS Associates.

The global cell therapy manufacturing market is estimated to grow from USD 4.90 billion in the current year to USD 13.83 billion by 2035, at a CAGR of 9.90% during the forecast period, till 2035.

But significant cell therapy manufacturing challenges need to be addressed for both autologous and allogeneic therapies to get these lifesaving cures to a greater population of individuals in need.

New York, USA, March 05, 2025 (GLOBE NEWSWIRE) -- Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight The growing incidence of genetic disorders and ...

CHICAGO, July 20, 2021 /PRNewswire/ -- According to the new market research report "Cell and Gene Therapy Manufacturing Services Market by Type (Allogeneic, Autologous, Viral Vector, Non-viral ...

At least six biotech startups have launched since 2017 to address shortfalls in cell and gene therapy manufacturing. The most richly funded, ElevateBio, has raised about $1.3 billion since it ...

Cellares unveiled Cell Q Thursday, the first automated quality control (QC) workcell for cell therapy manufacturing.. According to the company, Cell Q complements its Cell Shuttle Platform by ...

Cell therapy developers talked about the challenges of manufacturing these therapies at scale. Gerlinghaus teamed up with two other Synthego veterans, Omar Kurdi and Alex Pesch, to co-found ...

Dublin, Feb. 21, 2020 (GLOBE NEWSWIRE) -- The "Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030" report has been added to ResearchAndMarkets.com's offering. Cell Therapy Manufacturing ...

Cellares is the world’s first Integrated Development and Manufacturing Organization (IDMO) – and its Cell Shuttle represents a leap forward in cell therapy manufacturing, with integration and ...